Filing Flows › DarioHealth (DRIO) › Q1 2026 › vs Q1 2025
DarioHealth (DRIO) Q1 2026 vs Q1 2025 (year over year)
DarioHealth's revenue fell $1.2M (-17%) from $6.8M in Q1 2025 to $5.6M in Q1 2026. The biggest changes: Services −$2.0M (-42%); Hardware and Consumable Products +$881K (+47%).
DarioHealth, Q1 2026: revenue $5.6M (-17% year over year), operating margin -130.9%, net loss $8.2M, operating cash flow −$6.0M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Services | $2.8M | $4.9M | −$2.0M | -42% |
| Hardware and Consumable Products | $2.8M | $1.9M | $881K | +47% |
| Revenue | $5.6M | $6.8M | −$1.2M | -17% |
| Net loss | $8.2M | $9.2M | −$978K | -11% |
| Costs & expenses | $13.8M | $16.2M | −$2.4M | -15% |
| Operating costs | $12.9M | $16.2M | −$3.3M | -20% |
| Interest & other, net | $883K | −$204K | $1.1M | — |
| Income tax | $57K | $22K | $35K | +159% |
| Cost of revenue | $2.4M | $2.9M | −$486K | -17% |
| Research & development | $2.4M | $4.1M | −$1.7M | -42% |
| Sales & marketing | $4.9M | $5.9M | −$975K | -17% |
| General & admin | $3.2M | $3.3M | −$84K | -3% |
| Operating cash sources | $8.2M | $9.2M | −$978K | -11% |
| Depreciation & amortization | $524K | $1.3M | −$732K | -58% |
| Share-based compensation | $1.4M | $2.3M | −$901K | -38% |
| Working capital & other | $259K | −$1.0M | $1.3M | — |
| Cash used in operations | $6.0M | $6.7M | −$648K | -10% |
| Net loss absorbed | $8.2M | $9.2M | −$978K | -11% |
Questions
How much did DarioHealth's revenue grow year over year in Q1 2026?
DarioHealth's revenue fell $1.2M (-17%) from $6.8M in Q1 2025 to $5.6M in Q1 2026.
What drove DarioHealth's revenue change in Q1 2026?
Services −$2.0M (-42%); Hardware and Consumable Products +$881K (+47%).